UPDATE: Leerink Swann Upgrades Array BioPharma (ARRY) to Outperform; Exciting Data Help Leverage to MEK Inhibitors
Go back to UPDATE: Leerink Swann Upgrades Array BioPharma (ARRY) to Outperform; Exciting Data Help Leverage to MEK Inhibitors| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 4.69 -0.02 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.71 | 52 Week High | $7.27 | |||
| Open | $4.75 | 52 Week Low | $2.39 | |||
| Day High | $4.80 | P/E | N/A | |||
| Day Low | $4.63 | EPS | $-0.61 | |||
| Volume | 8,283,330 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 3,179,791 | |||||
| NOVARTIS AG (NYSE: NVS) | Delayed: 158.86 +2.62 (1.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $156.24 | 52 Week High | $89.15 | |||
| Open | $156.17 | 52 Week Low | $69.84 | |||
| Day High | $159.72 | P/E | N/A | |||
| Day Low | $156.10 | EPS | $0.00 | |||
| Volume | 1,183,726 | |||||

